Patient-important outcomes in diabetes - time for consensus

被引:40
作者
Montori, Victor M.
Gandhi, Gunjan Y.
Guyatt, Gordon H.
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, Div Endocrinol Diabet Metab Nutr & Internal Med, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA
[2] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON, Canada
关键词
D O I
10.1016/S0140-6736(07)61489-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1104 / 1106
页数:3
相关论文
共 11 条
[1]  
Guyatt Gordon, 2004, ACP J Club, V140, pA11
[2]   Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].
Kahn, Steven E. ;
Haffner, Steven M. ;
Heise, Mark A. ;
Herman, William H. ;
Holman, Rury R. ;
Jones, Nigel P. ;
Kravitz, Barbara G. ;
Lachin, John M. ;
O'Neill, M. Colleen ;
Zinman, Bernard ;
Viberti, Giancarlo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443
[3]   Systematic evaluation of the quality of randomized controlled trials in diabetes [J].
Montori, Victor M. ;
Grace, Yaqian ;
Alonso-Coello, Pablo ;
Bhagra, Sumit .
DIABETES CARE, 2006, 29 (08) :1833-1838
[4]   A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes [J].
Montori, VM ;
Gafni, A ;
Charles, C .
HEALTH EXPECTATIONS, 2006, 9 (01) :25-36
[5]   Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J].
Nathan, DM ;
Cleary, PA ;
Backlund, JYC ;
Genuth, SM ;
Lachin, JM ;
Orchard, TJ ;
Raskin, P ;
Zinman, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2643-2653
[6]   Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus [J].
Nissen, SE ;
Wolski, K ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (20) :2581-2586
[7]   Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].
Nissen, Steven E. ;
Wolski, Kathy .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471
[8]   Effect of torcetrapib on the progression of coronary atherosclerosis [J].
Nissen, Steven E. ;
Tardif, Jean-Claude ;
Nicholls, Stephen J. ;
Revkin, James H. ;
Shear, Charles L. ;
Duggan, William T. ;
Ruzyllo, Witold ;
Bachinsky, William B. ;
Lasala, Gregory P. ;
Tuzcu, E. Murat .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) :1304-1316
[9]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[10]   Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].
Turner, RC ;
Holman, RR ;
Stratton, IM ;
Cull, CA ;
Matthews, DR ;
Manley, SE ;
Frighi, V ;
Wright, D ;
Neil, A ;
Kohner, E ;
McElroy, H ;
Fox, C ;
Hadden, D .
LANCET, 1998, 352 (9131) :854-865